Recent publications showed a significantly higher risk for hepatic steatosis, more pronounced necroinflammation and an accelerated fibrosis progression rate in HCV monoinfected patients harbouring the PNPLA3 risk allele G [19–21]. Here, PNPLA3 is linked to Hepatic steatosis.